Brain circuits may begin malfunctioning decades before Alzheimer's disease symptoms emerge, offering a critical window for early intervention. This discovery challenges the assumption that genetic risk factors only matter once neurodegeneration is visible, suggesting prevention strategies could target much younger adults.
Young mice carrying the APOE4 gene variant showed abnormal electrical activity in hippocampal memory circuits long before any cognitive decline appeared. The hyperexcitable neurons were physically smaller and fired more readily than normal, creating an imbalanced network prone to dysfunction. When researchers selectively removed APOE4 from neurons while leaving it intact in other brain cells, the abnormal activity disappeared entirely. As these mice aged, the initial hyperexcitability evolved into broader network breakdown, with inhibitory neurons failing to properly regulate excitatory signals—a pattern characteristic of Alzheimer's pathology.
RNA sequencing identified Nell2 as a key molecular driver of this early dysfunction. When scientists used CRISPR technology to reduce Nell2 expression, the abnormal brain activity normalized, pinpointing a specific therapeutic target.
These findings suggest APOE4 carriers—roughly 25% of the population—may experience subtle brain circuit changes starting in young adulthood, decades before memory problems begin. This represents a paradigm shift from viewing Alzheimer's as primarily a disease of protein aggregation in older adults to recognizing it as a lifelong trajectory of network dysfunction. The research opens possibilities for preventive treatments targeting hyperexcitability in presymptomatic individuals, potentially altering the disease course before irreversible damage accumulates.
